Direct Targeting of Oncogenic RAS Mutants With a Tumor-Specific Cytosol-Penetrating Antibody Inhibits RAS Mutant–driven Tumor Growth

Science advances - United States
doi 10.1126/sciadv.aay2174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Targeting Oncogenic Ras

Genes and Development
GeneticsDevelopmental Biology
2007English

MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-Ras via AKT and ERK Signalings

Frontiers in Oncology
Cancer ResearchOncology
2019English

Oncogenic Synergism Between ErbB1, Nucleolin, and Mutant Ras

Cancer Research
Cancer ResearchOncology
2011English

Tumor-Specific Delivery of KRAS siRNA With iRGD-exosomes Efficiently Inhibits Tumor Growth

ExRNA
2019English

Two Types of RAS Mutants That Dominantly Interfere With Activators of RAS.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1994English

WDR76 Is a RAS Binding Protein That Functions as a Tumor Suppressor via RAS Degradation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Oncogenic Ras Stimulates Eiger/TNF Exocytosis to Promote Growth

Development (Cambridge)
Developmental BiologyMolecular Biology
2014English

Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis

Cell
BiochemistryGeneticsMolecular Biology
2019English

A DNA Vaccine Targeting Angiomotin Inhibits Angiogenesis and Suppresses Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy